AZZ (AZZ) Q3 2025 Earnings Call Transcript

AZZ reported Q3 sales of $403.7 million, up 5.8% organically, with adjusted net income up 20.5% to $41.9 million and adjusted EBITDA at $90.7 million, or 22.5% of sales. Management narrowed and raised full-year guidance, lifting adjusted EPS to $5.00-$5.30 and adjusted EBITDA to $340 million-$360 million, while interest expense fell to $19.2 million and leverage improved to 2.6x debt/adjusted EBITDA. The company also highlighted strong free cash flow, $35 million of quarterly debt repayment, and ongoing M&A interest as leverage approaches its 2x target.

Analysis

AZZ is quietly morphing from a cyclical coatings story into a cash-compounding infrastructure platform: the key setup is not just margin resilience, but the combination of easing interest expense, declining leverage, and a multi-quarter capex roll-off as the new Washington plant transitions from spend to contribution. That creates a near-term earnings air pocket where reported growth can look modest while free cash flow inflects more sharply, especially once the company stops carrying the full burden of growth capex into fiscal 2026.

The bigger second-order effect is competitive. As leverage approaches the low-2x zone, AZZ can re-enter bolt-on M&A just as smaller galvanizing and coil-coating operators likely face higher financing costs and slower project conversion. That sets up a classic capacity-consolidation trade: AZZ can buy regional share at a lower multiple than the replacement cost of greenfield capacity, while competitors remain trapped in a pricing environment where they must pass through zinc and labor inflation but lack AZZ’s scale-driven productivity advantage.

The market may be underestimating the timing mismatch in the new facility. Washington is likely a fiscal 2026 story, not a fiscal 2025 story, so the near-term upside is more about mix and utilization of existing assets than headline capacity. If management executes the ramp without operational noise, consensus will likely have to lift 2026 EBITDA meaningfully later this year; if there is any certification or startup delay, the stock can de-rate quickly because the earnings bridge is increasingly dependent on a smoother second-half ramp.

The main risk is not end-demand collapse; it is project timing churn from tariffs, permitting, and rate sensitivity, which can push revenue between quarters without destroying demand. That makes AZZ more of a timing/re-rating trade than a pure volume story. A softer consensus could also be vulnerable if zinc inflation accelerates faster than pass-through, but historically that is less dangerous than a sharp drop in project starts because the company can flex cost structure faster than it can replace lost throughput.

Key Decisions for Investors

• Long AZZ on a 3-6 month horizon ahead of fiscal 2026 guidance; thesis is leverage-driven multiple expansion plus 2026 earnings step-up from Washington startup. Risk/reward improves on any pullback tied to quarter-to-quarter noise rather than demand deterioration.
• Buy AZZ Jan-2026 calls or call spreads to express the view that 2026 EBITDA revisions come later this year; use a spread structure to cap premium if the plant ramp is slower than expected.
• Pair trade: long AZZ / short higher-leverage regional industrials or coatings names with similar end-market exposure, capturing AZZ’s lower financing risk and superior cash conversion as rates stay elevated.
• Take a tactical long in STLD only as a hedge, not as the core idea; AZZ should benefit more from downstream fabrication/coating activity than raw steel exposure, so avoid overexposing to upstream steel beta.
• If AZZ rallies toward pre-guidance optimism without evidence of Washington ramp execution, trim 25-30% and wait for the 2026 guide. The stock is likely to react more to startup credibility than to the already-improving 2025 numbers.